SVA vs AMGN: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Amgen Inc in 2026
SVA
Sinovac Biotech Ltd
$6.47
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | SVA | AMGN | Winner |
|---|---|---|---|
| Market Cap | $642.44M | $188.34B | AMGN |
| P/E Ratio | 6.66 | 24.57 | SVA |
| EPS (TTM) | $0.97 | $14.22 | AMGN |
| Revenue Growth | 3.0% | 0.1% | SVA |
| Gross Margin | 86.8% | 70.8% | SVA |
Analyze SVA
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or AMGN a better investment?
Comparing SVA and AMGN: Sinovac Biotech Ltd has a market cap of $642.44M while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and AMGN?
SVA (Sinovac Biotech Ltd) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or AMGN?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 24.6x).
Which is growing faster: SVA or AMGN?
SVA has higher revenue growth at 3.0% vs 0.1% for AMGN.
Which company is more profitable: SVA or AMGN?
Sinovac Biotech Ltd (SVA) has higher gross margins at 86.8% compared to 70.8% for AMGN.
Which is the larger company: SVA or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $642.44M for SVA.
Should I buy SVA or AMGN in 2026?
Both SVA and AMGN have investment merit. SVA trades at $6.47 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and AMGN stock?
Key differences: Market Cap ($642.44M vs $188.34B), P/E Ratio (6.7x vs 24.6x), Revenue Growth (3.0% vs 0.1%), Gross Margin (86.8% vs 70.8%).